Transfusion of Prematures Trial

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

1,824

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

January 31, 2020

Study Completion Date

August 31, 2025

Conditions
Infant, Newborn, DiseasesInfant, Extremely Low Birth WeightInfant, Small for Gestational AgeBronchopulmonary Dysplasia (BPD)Anemia
Interventions
PROCEDURE

Liberal Cell Transfusion

PROCEDURE

Restricted red cell transfusion

Trial Locations (20)

14642

University of Rochester, Rochester

19104

Univeristy of Pennsylvania, Philadelphia

27705

RTI International, Durham

27710

Duke University, Durham

30303

Emory University, Atlanta

35233

University of Alabama at Birmingham, Birmingham

43205

Research Institute at Nationwide Children's Hospital, Columbus

44106

Case Western Reserve University, Rainbow Babies and Children's Hospital, Cleveland

45267

Cincinnati Children's Medical Center, Cincinnati

46202

Indiana University, Indianapolis

48201

Wayne State University, Detroit

52242

University of Iowa, Iowa City

64108

Children's Mercy Hospital, Kansas City

75235

University of Texas Southwestern Medical Center at Dallas, Dallas

77030

University of Texas Health Science Center at Houston, Houston

84108

University of Utah, Salt Lake City

87131

University of New Mexico, Albuquerque

90025

University of California - Los Angeles, Los Angeles

94304

Stanford University, Palo Alto

02905

Brown University, Women & Infants Hospital of Rhode Island, Providence

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

NICHD Neonatal Research Network

NETWORK

NCT01702805 - Transfusion of Prematures Trial | Biotech Hunter | Biotech Hunter